ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0418

Synovial Fluid Cell Counts Associated with Joint Histopathology in Rheumatoid Arthritis

Edoardo Spolaore1, Edward DiCarlo2, Daniel Ramirez2, Melanie Smith2, Amit Lakhanpal2, Bella Mehta3, Laura Donlin2, Susan Goodman2 and Dana Orange4, 1HSS, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4The Rockefeller University, New York, NY

Meeting: ACR Convergence 2023

Keywords: Inflammation, Pathology Bone Joint, rheumatoid arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: While analysis of synovial fluid white blood cell counts (WBCs) is performed in clinical practice for diagnosing septic arthritis and differentiating noninflammatory from inflammatory forms of arthritis, the connection between features of paired synovial fluid and tissue has not been explored. This study seeks to explore the relationship between paired synovial fluid cell counts, synovial histopathology, clinical features, and disease activity.

Methods: Patients meeting ACR/EULAR 1987 and/or 2010 rheumatoid arthritis (RA) classification criteria were recruited prior to elective total knee arthroplasty. All patients provided written informed consent (HSS IRB # 2014-233). Demographics, RA patient reported outcome measures (PROMs), tender and swollen joints, ESR, CRP, RF, and CCP were collected. Synovial fluid was obtained via arthrocentesis performed immediately before surgery. Absolute and differential cell counts were performed, and synovial histopathology using hematoxylin and eosin (H&E) was performed on tissue. An expert musculoskeletal pathologist scored 14 synovial histologic findings: synovial lymphocytic inflammation, mucoid change, fibrosis, fibrin, germinal centers, lining hyperplasia, polymorphonuclear neutrophils (PMNs), detritus, plasma cells, binucleated plasma cells, Russell bodies, sub-lining giant cells, synovial lining giant cells, and mast cells (available at www.hss.edu/pathology-synovitis). Relationships between synovial fluid and tissue data were measured with Pearson’s correlations.

Results: We included 25 patients. Mean age = 68.12 years, mean disease duration = 16.25 years, indicating longstanding disease, mean DAS28-ESR = 4.86 indicating moderate disease activity. Further characteristics of the cohort divided by noninflammatory vs inflammatory synovial fluid (WBC threshold of 2000 cells/microL) are included (Table 1). Synovial fluid WBC was positively correlated with synovial lymphocytic inflammation (SLI), neutrophil infiltration, CRP, and ESR. Of the other synovial histologic features, mucoid degeneration approached significance. Percentage of PMNs in the synovial fluid was positively correlated with PMN infiltration. Percentage of monocytes in the synovial fluid was negatively correlated with PMN infiltration and SLI. Synovial fluid total WBC had no significant correlation with disease activity or PROMs in our cohort. Overview of correlations with associated statistical values included (Table 2, Table 3).

Conclusion: Preliminary results suggest that synovial fluid characteristics are informative and correlate with inflammation in the underlying synovial tissue, but not with disease activity. CRP, present in subclinical synovitis,1 is strongly correlated with synovial fluid WBC. Further analysis of synovial fluid might increase insight into RA pathophysiology and disease control.

References

1. Orange DE, Agius P, DiCarlo EF, et al. Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol Hoboken NJ. 2019;71(7):1034-1041. doi:10.1002/art.40878

Supporting image 1

1 = mean (SD)
2 = n(%)
*Between groups p-value calculated using t-test.
RF = rheumatoid factor; CCP = cyclic citrullinated protein; ESR = erythrocyte sedimentation rate; CRP = C Reactive Protein; DAS28 = disease activity score using 28 joints; CDAI = clinical disease activity index; WBC = absolute white blood cell count; Polys% = percentage white blood cells in synovial fluid that are polymorphonuclear neutrophils; Monos% = percentage white blood cells in synovial fluid that are monocytes; Lymphs(%) = percentage white blood cells in synovial fluid that are lymphocytes; PMN = polymorphonuclear neutrophils;
Bolded values significant p<0.05

Supporting image 2

Supporting image 3


Disclosures: E. Spolaore: None; E. DiCarlo: None; D. Ramirez: None; M. Smith: None; A. Lakhanpal: None; B. Mehta: Janssen, 1, Novartis, 5; L. Donlin: Bristol-Myers Squibb(BMS), 2, Stryker, 2; S. Goodman: NIH, 5, Novartis, 5; D. Orange: AstraZeneca, 2, Pfizer, 2.

To cite this abstract in AMA style:

Spolaore E, DiCarlo E, Ramirez D, Smith M, Lakhanpal A, Mehta B, Donlin L, Goodman S, Orange D. Synovial Fluid Cell Counts Associated with Joint Histopathology in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/synovial-fluid-cell-counts-associated-with-joint-histopathology-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fluid-cell-counts-associated-with-joint-histopathology-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology